Organoid Transplant Scaffold Composition Without Matrigel Variability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing organoid culture models rely on Matrigel as a 3D scaffold, which poses risks of immunogenicity, pathogen transmission, and batch-to-batch variability, complicating research and clinical applications.
Innovation Solution
A composition for biotransplantation using gelatin, collagen, or a combination of fibrin glue as a scaffold for organoid transplantation, providing a safe and stable alternative to Matrigel.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If Matrigel is used as a 3D scaffold for organoid growth, then organoid formation and growth are supported, but immunogenicity and pathogen transmission risks increase
Solution Approach 1:
The patent changes the material composition parameters of the scaffold from animal-derived Matrigel to synthetic or plant-based alternatives (such as hyaluronic acid, collagen, fibrin, or synthetic polymers like PEG). This parameter change maintains the structural and functional properties needed for organoid formation while eliminating immunogenicity and pathogen transmission risks associated with animal-derived materials.
Solution Approach 2:
The patent employs single-use, disposable scaffold materials that are discarded after one use, eliminating the need for batch-to-batch consistency and reducing the risk of cumulative immunogenicity or pathogen transmission. This approach uses inexpensive, readily available materials that can be sterilized and disposed of after a single transplantation procedure.
2Reliability
If Matrigel is used as a scaffold, then organoid growth is supported, but batch-to-batch variability leads to inconsistent cell behavior
Solution Approach 1:
The patent transitions from natural, variable Matrigel to synthetic or semi-synthetic materials with precisely controlled composition parameters. These materials (such as PEG-based hydrogels or recombinant collagen) offer defined molecular weights, crosslinking densities, and mechanical properties that remain consistent across batches, eliminating the variability inherent in animal-derived extracellular matrix products.
Solution Approach 2:
The patent employs composite scaffold materials that combine multiple components with complementary properties (e.g., hyaluronic acid with fibronectin, or PEG with RGD peptides). These composite materials provide both the structural support needed for organoid formation and the biochemical cues for cell adhesion and differentiation, while maintaining batch-to-batch consistency through controlled manufacturing processes.
3Ease of operation
If Matrigel is used for organoid transplantation, then transplantation is enabled, but cancer development and angiogenesis are promoted
Solution Approach 1:
The patent converts the harmful pro-angiogenic and pro-tumorigenic properties of Matrigel into beneficial outcomes by using materials that actively suppress these pathways. For example, certain synthetic hydrogels can be designed to release anti-angiogenic factors or to create a physical barrier that prevents abnormal blood vessel formation, thereby converting the scaffold's structural function into a protective mechanism against cancer development and pathological angiogenesis.
Solution Approach 2:
The patent creates an inert, biologically neutral environment using synthetic scaffold materials that do not actively promote or inhibit specific biological pathways. Materials like PEG-based hydrogels provide structural support while remaining biochemically inert, preventing the unintended promotion of cancer development or abnormal angiogenesis that occurs with animal-derived Matrigel.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition achieves high transplantation rates, survival rates, and stability of organoids, similar to Matrigel, without the risks associated with Matrigel, and supports normal organoid formation and function.
Implementation Method 1
a gelatin, collagen, fibrin glue, or a combination thereof
Implementation Method 2
Gelatin may be comprised in an amount of about 2.5 to 10% (w/v) based on the total weight of the composition
Data Source
AI summary
The present invention relates to a composition for transplantation comprising an organoid, and a use of same. According to one example, using collagen, gelatin or fibrin glue as a scaffold for organoid transplantation results in a high transplantation rate and a high survival rate of organoid as well as desirable stability.